Business
CSL (ASX:CSL) share price heads lower on haemophilia B deal
The CSL Limited (ASX: CSL) share price is slightly lower today despite announcing plans to buy rights for novel late-stage gene therapy candidate.
In late afternoon trade, the global biotech’s shares are swapping hands for $276.06, down 0.5%.
What did CSL announce?
Investors appear…
Continue Reading
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News24 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General24 hours agoFederal politics live: Government says RBA rate cut decision about ‘pace, not direction’
-
General23 hours agoReserve Bank board still looking for yesterday’s news